Slides on Precision Management of Late Endocrine Effects in Cancer Survivors

Learn how to look for and manage the many late endocrine effects of childhood cancer and its treatments, including hypothalamic pituitary dysfunction, thyroid disorders, obesity and diabetes mellitus.
Wassim Chemaitilly, MD
Laurie E. Cohen, MD
Danielle N. Friedman, MD, MS
Steven G. Waguespack, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.61 MB
Released: March 18, 2021

Acknowledgements

Provided by the Endocrine Society

For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.

In collaboration with Clinical Care Options
Supported by an educational grant from
Novo Nordisk Inc.

Related Content

Learn about obesity management for long-term weight loss and CVD risk reduction; focus on new and emerging incretin therapies, eg, GLP-1 agonists, from Clinical Care Options (CCO)

person default Fatima Cody Stanford, MD, MPH, MPA, MBA Released: June 8, 2021

CCO Slides on T2D: Latest expert advice on SGLT2 inhibitors to prevent and manage heart failure, including HFrEF and HFpEF, in type 2 diabetes.

Jennifer B. Green, MD Mikhail N. Kosiborod, MD Released: June 7, 2021

Nancy E. Lane, MD: Commentary on estrogen, anabolic agents, and steroids in the treatment of osteoporosis, from Clinical Care Options (CCO)

person default Nancy E. Lane, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: May 25, 2021 Expired: May 24, 2022

Nelson Watts, MD: Commentary with expert answers on primary care management of fracture risk, T-scores, osteoporosis in men, from Clinical Care Options (CCO)

person default Nelson Watts, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: May 24, 2021 Expired: May 23, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue